FPHAX Mutual Fund (Fidelity Select Pharmaceuticals Portfolio) is managed by Fidelity Investments (US) with $702.6M in net assets. FPHAX expense ratio is 0.67%, holding 60 positions across sectors including Health Care, Unknown, Financials. Inception date: 2001-06-18.

FPHAX performance shows a YTD return of 15.56%. The 1-year return is 49.65% and the 5-year return is 14.65%. FPHAX dividend yield stands at 4.81%, paid semi-annually.

FPHAX top holdings include Eli Lilly & Co (25.2%), Glaxosmithkline Finance Plc (10.1%), Johnson & Johnson (7.5%), Ucb Sa (5.0%), AstraZeneca PLC (4.9%). View all FPHAX holdings, sector breakdown, or dividend history.

FPHAX can be compared against other funds using the overlap calculator or side-by-side comparison tool. FPHAX alternatives are available via the screener, along with tax-loss harvesting opportunities.